Precision Medicine For Your PracticePrenatal Cell-Free DNA Screening

Developed in collaboration with

Learning Objectives
1. Determine if cell-free DNA screening is a good fit for the patient
2. Interpret results of cell-free DNA screening in the context of the patient characteristics

0.5 Credit CME

Clinical Education from The Jackson Laboratory

Activity Information and Disclosures

Published Online: August 25, 2016 Precision Medicine

Module Take Quiz

Precision Medicine for Your Practice is a series of short (approximately 30 min), online modules covering specific topics in genomics and precision medicine. In this module, Prenatal Cell-free DNA Screening, participants will learn about the benefits and limitations of cell-free DNA screening in prenatal care. Prenatal providers and patients have more options than ever for screening for Down syndrome and other chromosome conditions, including cell-free DNA screening. While cell-free DNA screening, also called noninvasive prenatal testing, is a powerful tool, it is not the best test for all pregnant people. Learn about specific benefits, limitations, and challenges in results interpretation and counseling using the five parts of this module: overview information via an animated video; practice cases to facilitate learning-by-doing; “dig deeper” activities; logistics; and additional resources for more detail.

Take Quiz

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

0.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;

0.5 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;

0.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;

0.5 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and

0.5 CME points in the American Board of Surgery’s (ABS) Continuing Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Activity Information

AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships.

If applicable, all relevant financial relationships have been mitigated.

Credit Renewal Dates: August 22, 2019, August 21, 2022

Disclosure Statement: In order to assure the highest quality of certified CME programming, and to comply with the ACCME Standards for Commercial Support, the AMA requires that all faculty, planners and members of the AMA CME Program Committee disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. The following disclosures are provided:

• Siobhan Dolan, MD, MPH, Stockholder of Sequenom

• Jeanette McCarthy, PhD, MPH, Consultant to Big Science Media, Omicia, and Precision Medicine Advisors

• Colleen Schmitt, MS, CGC, Employee of Counsyl, Inc.

• Suzanna Schott, ScM, CGC, Stockholder of Merck, Amgen, and Teva

• Janet K. Williams, PhD, RN, FAAN, Stockholder of Pfizer

No other planners or faculty have relevant financial relationships to disclose.

Precision Medicine For Your PracticePrenatal Cell-Free DNA Screening

Please finish the activity before taking the quiz.

AMA Membership provides:

Sign in to access

Sign in to customize your interests

Name Your Search

Sign in to save your search

Lookup An Activity

My Saved Searches

My Saved Courses

Purchase access